What does VIANOVIX do?

VIANOVIX is a market research agency in Zele. Private Limited, started on 5 October 2017, 1 establishment.

What is the address of VIANOVIX?

The registered office of VIANOVIX is located at Bakkerstraat 95, 9240 Zele.

Is VIANOVIX still active?

Yes. According to the CBE (30 October 2026) VIANOVIX is active, legal situation “Normale toestand”, started on 5 October 2017.

Is VIANOVIX registered on Peppol?

Yes, VIANOVIX is registered on the Peppol network with ID 0208:0682565541.

What is the enterprise number of VIANOVIX?

The enterprise number of VIANOVIX is BE0682565541.

When was VIANOVIX founded?

VIANOVIX was founded on 5 October 2017.

Who are the directors of VIANOVIX?

According to the 2025 annual accounts, the directors of VIANOVIX are: Anita Van Avermaet, Katrien Michiels.

Is VIANOVIX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 October 2017; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did VIANOVIX make in 2025?

VIANOVIX recorded a loss after taxes of € 835 in financial year 2025.

What is the revenue of VIANOVIX?

As a small company, VIANOVIX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 58,727.

Does VIANOVIX have a website?

Yes, VIANOVIX has a website at vianovix.com.

VIANOVIX (Private Limited) - Zele - BE0682565541

Dossier VIANOVIX, printed on 30 October 2026 from databakkes.be/en/0682565541/vianovix. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

VIANOVIX from Zele, company number BE0682565541, closed financial year 2025 with a result of € -835 after tax. For that financial year VIANOVIX recorded a gross margin of € 58,727 and equity of € 42,466. Compared with financial year 2024, the result moved from € -99,215 to € -835. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 5, 2026.

What it is worth Healthy

€ 42,466

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -835

▲ 99 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 36,525

▲ € 31,262 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 23,916.

Debts at end 2025

Bank debt

€ 1.1 million

▲ 78% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 11,364

▼ 76% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 17,330 Gross margin 2022: € 17,330 First fiscal year in the series	€ 130,433 Gross margin 2023: € 130,433 ▲ € 113,104 vs 2022 (€ 17,330) Favourable step	€ -53,388 Gross margin 2024: € -53,388 ▼ € 183,821 vs 2023 (€ 130,433) Unfavourable step	€ 58,727 Gross margin 2025: € 58,727 ▲ € 112,115 vs 2024 (€ -53,388) Favourable step	▲ € 112,115
Profit after taxes	€ 8,196 Profit after taxes 2022: € 8,196 First fiscal year in the series	€ 107,111 Profit after taxes 2023: € 107,111 ▲ € 98,915 vs 2022 (€ 8,196) Favourable step	€ -99,215 Profit after taxes 2024: € -99,215 ▼ € 206,326 vs 2023 (€ 107,111) Unfavourable step	€ -835 Profit after taxes 2025: € -835 ▲ € 98,380 vs 2024 (€ -99,215) Favourable step	▲ € 98,380
Equity	€ 35,405 Equity 2022: € 35,405 First fiscal year in the series	€ 142,516 Equity 2023: € 142,516 ▲ € 107,111 vs 2022 (€ 35,405) Favourable step	€ 43,301 Equity 2024: € 43,301 ▼ 70% vs 2023 (€ 142,516) Unfavourable step	€ 42,466 Equity 2025: € 42,466 ▼ 2% vs 2024 (€ 43,301) Unfavourable step	▼ 2%
Total debts	€ 353,355 Total debts 2022: € 353,355 First fiscal year in the series	€ 330,658 Total debts 2023: € 330,658 ▼ 6% vs 2022 (€ 353,355) Favourable step	€ 657,101 Total debts 2024: € 657,101 ▲ 99% vs 2023 (€ 330,658) Unfavourable step	€ 1,086,344 Total debts 2025: € 1,086,344 ▲ 65% vs 2024 (€ 657,101) Unfavourable step	▲ 65%
Cash	€ 84,691 Cash 2022: € 84,691 First fiscal year in the series	€ 105 Cash 2023: € 105 ▼ € 84,587 vs 2022 (€ 84,691) Unfavourable step	€ 5,263 Cash 2024: € 5,263 ▲ € 5,158 vs 2023 (€ 105) Favourable step	€ 36,525 Cash 2025: € 36,525 ▲ € 31,262 vs 2024 (€ 5,263) Favourable step	▲ € 31,262
Retained profit	€ 16,855 Retained profit 2022: € 16,855 First fiscal year in the series	€ 123,966 Retained profit 2023: € 123,966 ▲ € 107,111 vs 2022 (€ 16,855) Favourable step	€ 24,751 Retained profit 2024: € 24,751 ▼ 80% vs 2023 (€ 123,966) Unfavourable step	€ 23,916 Retained profit 2025: € 23,916 ▼ 3% vs 2024 (€ 24,751) Unfavourable step	▼ 3%
Bank debt	€ 281,139 Bank debt 2022: € 281,139 First fiscal year in the series	€ 222,974 Bank debt 2023: € 222,974 ▼ 21% vs 2022 (€ 281,139) Favourable step	€ 599,063 Bank debt 2024: € 599,063 ▲ 169% vs 2023 (€ 222,974) Unfavourable step	€ 1,064,892 Bank debt 2025: € 1,064,892 ▲ 78% vs 2024 (€ 599,063) Unfavourable step	▲ 78%
Balance sheet total	€ 388,760 Balance sheet total 2022: € 388,760 First fiscal year in the series	€ 473,174 Balance sheet total 2023: € 473,174 ▲ 22% vs 2022 (€ 388,760) Unchanged	€ 700,403 Balance sheet total 2024: € 700,403 ▲ 48% vs 2023 (€ 473,174) Unchanged	€ 1,128,810 Balance sheet total 2025: € 1,128,810 ▲ 61% vs 2024 (€ 700,403) Unchanged	▲ 61%

Key figures of VIANOVIX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VIANOVIX?

What happened at VIANOVIX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 5, 2026 New annual accounts for financial year 2025: loss of € 835. filed late Source: NBB ↗
2019 Anita Van Avermaet became a director. NBB
2019 Katrien Michiels became a director. NBB
Oct 5, 2017 New establishment in Zele. KBO
Oct 5, 2017 Start of the company according to the CBE. KBO

In short

From € 8,196 profit in 2022 to € 835 loss in 2025.

Best year ever: 2023, with € 107,111 profit.

Original PDFs at the National Bank ↗

Management

Anita Van Avermaet Katrien Michiels

UMISOL GROUP

VIANOVIX

Group Michiels Advanced Materials

MICHIELS GROUP

Behind VIANOVIX are Anita Van Avermaet and Katrien Michiels. The same people are also behind UMISOL GROUP. Katrien Michiels is also behind Group Michiels Advanced Materials, MICHIELS GROUP, ELYSE and MICHIELS REAL ESTATE.

Directors

According to the 2025 annual accounts

Anita Van Avermaet

Director

Also active at: UMISOL GROUP

since 2019

Katrien Michiels

Director

Also active at: Group Michiels Advanced Materials, UMISOL GROUP, MICHIELS GROUP, ELYSE, MICHIELS REAL ESTATE

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Bakkerstraat 95

9240 Zele

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

BHM MANAGEMENT

€ 13,543 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS vianovix.com

Technologies

ApacheContact Form 7Font AwesomeGoogle FontsPHPSwiperWPBakeryWordPressjQueryreCAPTCHA

Hosting & Email

Email provider

Microsoft 365

Hosting

CLDIN-NL Your Hosting B.V. part of Your.Online, NL

Domain

vianovix.com

Registered

2017-10-09

Registrar

Realtime Register B.V.

Expires

2026-10-09

Website info

HTTPS Ja

Languages DE, EN

Features

Webshop Blog Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0682.565.541

VAT number

BE 0682.565.541

Registered office

Bakkerstraat 95, 9240 Zele

Names & denominations

VIANOVIX

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

5 October 2017

Peppol

Active · Active since 21 Oct 2026

Contact

vianovix.com [email protected] 052/307605

Activities · NACE

Markt- en opinieonderzoek

Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht

View on CBE Public ↗ Annual accounts (NBB) ↗

VIANOVIX

Warning lights

Financials

What happened to VIANOVIX?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Network

Details

Frequently asked questions